## **Core Concept**
The question revolves around the administration of succinylcholine, a depolarizing neuromuscular blocking agent, to a paraplegic patient, leading to severe cardiac complications. This scenario highlights the importance of understanding the physiological changes in paraplegic patients and the side effects of succinylcholine.

## **Why the Correct Answer is Right**
The correct answer, **D. Hyperkalemia**, is the most likely cause of the observed symptoms. Succinylcholine can cause a significant release of potassium ions (K+) from muscle cells, leading to hyperkalemia. In paraplegic patients, there is often muscle denervation, which alters the expression of acetylcholine receptors on the muscle surface. When succinylcholine is administered, it can cause a massive release of potassium from denervated muscles, leading to potentially life-threatening hyperkalemia. This condition can cause dysrhythmias, conduction abnormalities, and eventually cardiac arrest.

## **Why Each Wrong Option is Incorrect**
- **Option A: Hypokalemia** is incorrect because it would not cause the symptoms described. Hypokalemia can lead to cardiac arrhythmias but is less directly linked to the acute administration of succinylcholine in a paraplegic patient.
- **Option B: Hypocalcemia** is incorrect as it is not directly related to the administration of succinylcholine and the specific context of paraplegia leading to cardiac complications.
- **Option C: Acidosis** is incorrect because, while acidosis can have cardiac effects, it is not the most direct consequence of succinylcholine administration in a paraplegic patient.

## **Clinical Pearl / High-Yield Fact**
A crucial point to remember is that patients with conditions leading to muscle denervation (like paraplegia) are at risk of severe hyperkalemia when administered succinylcholine. This risk necessitates careful consideration of alternative neuromuscular blocking agents or adequate preparation to manage potential hyperkalemia.

## **Correct Answer: D. Hyperkalemia**